People in their 50s are returning bowel cancer screening kits at lower rates than other age groups, according to annual figures released by NHS England covering the period April 2024 to March 2025. The data has prompted NHS England to call for greater participation among this demographic, particularly given that the screening programme is currently identifying approximately 100 bowel cancers per week across the population it serves.
Participation Rates Among Those in Their 50s
The NHS England figures show that just 56.2% of 54-year-olds completed bowel cancer screening during the 2024–25 reporting year. That figure places this age group behind older cohorts in terms of kit return rates, a pattern that health officials have flagged as a concern given the potential for early detection to alter clinical outcomes.
The bowel screening programme works by sending home testing kits, which participants complete and return by post. The test checks for traces of blood in stool samples — a potential indicator of bowel cancer or pre-cancerous conditions — without requiring a clinical appointment. The relative simplicity of the process makes the comparatively low uptake among people in their 50s a focus of NHS England's current messaging.
What the Weekly Detection Rate Signals
The finding that roughly 100 bowel cancers are identified through the programme each week underscores the scale at which screening is operating. Across a full year, that rate would correspond to thousands of cases detected at a stage when treatment options are generally broader. NHS England's annual figures present this detection volume as evidence of the programme's reach, while simultaneously highlighting that lower participation in certain age groups may mean some cases go undetected longer than they otherwise might.
Bowel cancer, when identified at an early stage, is associated with considerably better clinical outcomes than when it is found after symptoms have become apparent. Screening programmes are designed specifically to surface cases before symptoms develop, which is why participation rates carry particular weight in public health assessments of the programme's effectiveness.
Why the 50s Age Group Matters
The expansion of bowel cancer screening eligibility to include people in their 50s was itself a relatively recent development within the NHS programme. Bringing a younger cohort into routine screening was intended to extend the window during which early-stage disease could be caught. The NHS England data suggests that, despite eligibility, a substantial proportion of this group — nearly one in two 54-year-olds — did not return their kit during the most recent reporting year.
NHS England has not, in the current release, detailed the specific reasons behind lower uptake in this age group. Participation in screening programmes is shaped by a range of factors that vary across populations and geographies, and the figures alone do not identify a single cause for the gap observed among people in their 50s.
The Broader Screening Picture
The annual bowel screening figures released by NHS England serve as a regular benchmark for how the programme is performing across different demographic groups. The 2024–25 data adds to a body of evidence that participation rates are uneven, and that targeted efforts to reach lower-responding groups remain an ongoing feature of NHS public health strategy.
For those within the eligible age range who have received a screening kit, the NHS England data reinforces the programme's stated position: that returning the kit represents one of the more straightforward steps available for detecting bowel cancer at an early stage. Whether that message translates into meaningfully higher participation rates among people in their 50s in the next reporting cycle remains to be seen.